Scientific Sessions 2025  /  HFpEF in 2025: Trials and Triumphs  /  Exploring the Interplay Between Afib and HFpEF
Logo

American Heart Association

  52
  0

Final ID:

Exploring the Interplay Between Afib and HFpEF

  • Zakeri, Rosita  ( King's College London , London , United Kingdom )
  • Gersh, Bernard  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Tumolo, Alexis  ( University of Colorado Hospital , Aurora , Colorado , United States )
    • Author Disclosures:
    Rosita Zakeri: DO have relevant financial relationships ; Consultant:AstraZeneca:Past (completed) ; Other (please indicate in the box next to the company name):SERB Pharmaceuticals, publication fees:Past (completed) ; Speaker:Johnson & Johnson:Past (completed) ; Consultant:Boehringer Ingelheim:Past (completed) | Bernard Gersh: DO NOT have relevant financial relationships | Alexis Tumolo: DO have relevant financial relationships ; Speaker:Boston Scientific:Active (exists now) ; Other (please indicate in the box next to the company name):Abbott, Education:Active (exists now) ; Speaker:Biosense Webster:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

HFpEF in 2025: Trials and Triumphs

Monday, 11/10/2025 , 01:30PM - 02:45PM

Main Event

More abstracts on this topic:
The Changing Landscape of HF: HFpEF as The Predominant Form of HF

Ho Jennifer, Pandey Ambarish

The Future of HFpEF Treatment: Novel Pillars of Medical Therapy

Sweitzer Nancy, Solomon Scott, Mcdonagh Theresa

More abstracts from these authors:
Current and future management of AF in HF

Zakeri Rosita, Ellinor Patrick

Long QT Syndrome: What's the Long and Short of It?

Aziz Peter, Tzou Wendy, Ackerman Michael, Tumolo Alexis

You have to be authorized to contact abstract author. Please, Login
Not Available